Skip Navigation LinksNew Tests

Zika Virus Screening


As of 08/02/2016, Zika screening by PCR will be available from Eurofins Biomnis, with a turnaround time of six working days from receipt of sample.

Next Generation Sequencing Test for Cystic Fibrosis Mutation Analysis


Eurofins Biomnis is pleased to announce the availability of our Next Generation Sequencing test for Cystic Fibrosis mutation analysis which can detect 96% of the CFTR (cystic fibrosis transmembrane conductance regulator) gene mutations.


HE4/ROMA & Their Role in Ovarian Cancer


The diagnosis of ovarian cancer relies on clinical examination (abdominal and gynaecological examination) and imaging (scanner, MRI: work-up for extension). The diagnosis is confirmed by tissue sample analysis, which is carried out through laparoscopy or laparotomy.


Pre-eclampsia Prediction Screening


Pre-eclampsia is a complication that can occur during pregnancy. It is the number one cause of maternal morbi-mortality in the developed world and can be as high as 10% in high risk populations.


Hepatitis B analyses


Eurofins Biomnis is pleased to inform you that the following Hepatitis B analyses are now available in-house


Study of the polymorphism rs12979860


Study of the polymorphism rs12979860 - Prediction of the effectiveness of Hepatitis C treatment